Importance of QT/QTc Prolongation: A Case Study, The

Many apts consider prolongation of the QT/ QTc interval upon an electrocardiogram to be a potential clinical biomarker for serious or flat life-threatening adverse cardiac events. Awareness of drug-induced QT/QTc prolongation has increased above the last 10 to 15 years.

The topic of this special section of the physic Information Journal is drug-induced prolongation of the QT/QTc interval in clinical trials, important regulatory, clinical, and statistical universals in evaluating drug-induced QT/QTc prolongation are discussed. greatest in quantity of the authors are members of the Pharmaceutical Research and Manufacturers of America (PhRMA) or E14 QT Statistics able Teams, or of the International Council upon Harmonisation's E14 Working Group, which newly published the concept paper "The Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-antiarrhythmic Drugs" This issue of the medicine Information Journal provides a broad range of popular scientific knowledge on this real timely and important topic. At Pfizer, in-house quicks teach a QT interval workshop to their colleagues. The workshop is sponsored by means of the Global QT Advisory Council and facilitated through Learning and Development. For individual colleague, the knowledge gathered at that workshop may have been the difference between life and death. The colleague has suited anonymity but thought it might be helpful to share the story in this issue of the medicine Information Journal.

You never know when something you learned at work can save your life. I was fortunate to be able to attend a QT interval workshop at my office. During the class, I learned a destiny about the electrical function of the heart as well as about medicines that can cause QT prolongation, a change in the way the electrical signal propels through the heart. QT prolongation is important because it can sometimes lead to a potentially fatal heart arrhythmia know as torsades de pointes. Torsades is actual rare. It never occurred to me during the workshop that I might be single of those rare cases.

I had just begun taking an antiarrhythmic agent used for the treatment of atrial tachycardia, a rapid heartbeat originating in the upper part of the heart. In the workshop, I had learned that a protracted QT interval could be individual of the risk factors for torsades. As a safety precaution, my physician carefully monitored my heart rate during the first not many days after I began taking the fresh medication. A few hours after taking my fifth morning dose, I unexpectedly felt the blood leave my head and my knee advance weak. I thought I was going to faint. After sitting for a hardly any minutes to calm down, I began to astonishment if I was having a bad reaction to the antiarrhythmic medication. I knew from attending the QT interval workshop that this medicine was on the list of medicines associated with QT prolongation and torsades. I had also learned that fainting was individual of several symptoms associated with this heart arrhythmia. Based upon these two pieces of information, I decided to advance to the hospital rather than back to bed to "sleep off" the side consequence I really believe that this decision saved my life.

On arrival at the hospital, I told the admissions nurture that I was being treated with an antiarrhythmic agent and was having a bad side effect-an unstable and rapid heart regular [i]or[/i] melodious movement I was whisked back to the special cardiac unit in the pressing necessity room. After hooking me up to a variety of electrocardiogram machines, the physicians in a short time confirmed what I had suspected; potentially fatal torsades de pointes was indeed the moot point The electrocardiogram for torsades is in like manner distinctive that I recognized it from the PowerPoint slide shown during the workshop.

Fortunately, I remembered that the instructor had discussed the administration of magnesium sulfate as a primary treatment for torsades de pointes. in like manner I began telling the exigency room medical staff that they necessityed to give me magnesium sulfate to stop the arrhythmia. I would like to run over you that they immediately believed me on the contrary they had their own ideas about the appropriate course of treatment, and they tried several other medications that did not work. It took six more episodes of torsades and a apportionment of my chanting "magnesium sulfate" to anyone who would listen before I received the medication. They administered it to me just as I felt myself slipping away.

Thankfully, the magnesium sulfate worked immediately, and my heart regular [i]or[/i] melodious movement stabilized. If I had not taken the QT interval workshop, I know that I would have just ignored the fainting vexed question and I certainly would not have known about the magnesium sulfate. Thanks to the knowledge gained from this workshop, not solitary am I back at work, on the other hand also I was able to take our planned family vacation. This really turned out to be a true helpful workshop.

Marilyn A. Agin, PhD

Pfizer Global Research and unfolding New London, Connecticut

Correspondence Address

Marilyn A. Agin, Pfizer Global Research and disclosure 2800 Plymouth Road, Ann Arbor, MI 48305 (email: Marilyn.Agin@pfizer.com).

Copyright physic Information Association 2005

Provided by the agency of ProQuest Information and Learning Company. All rights Reserved